drugset / Trial / NCT01667575

Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.Pylori

NCT01667575

Phase 4 Completed 180 enrolled Shanghai Jiao Tong University School of Medicine
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to observe the efficacy of ten day triple therapy-based, bismuth-containing quadruple therapy for H.pylori treatment.

Timeline

Start
2012-08
Primary completion
2013-05
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Bismuth Potassium Citrate Unknown 220 mg
Background Amoxicillin Other / unclassified 1 g
Background Clarithromycin Small molecule 500 mg
Background Esomeprazole Small molecule 20 mg